Magnesium - Consumer

Trust note

What this source is and what it can support

Summary

NIH guidance on magnesium intake and safety; useful for deficiency, toxicity, and interaction context.

Why this source matters

The NIH Office of Dietary Supplements consumer fact sheet on magnesium is a strong public-health reference for understanding what magnesium is, who may be deficient, and when supplementation becomes risky.

This source is rated high quality because it comes from a federal nutrition authority with clear public-health expertise. The NIH is not selling magnesium, and this page is designed to give readers a practical summary of intake, deficiency, excess, and drug interactions.

What it supports is the safety and context side of the question: people with kidney disease can accumulate magnesium more easily, some medicines interact with magnesium, and the supplement should be treated more carefully than the casual wellness framing sometimes suggests. What it does not prove is that magnesium improves sleep or stress in healthy adults.

That distinction matters for the final answer. This source helps explain why the page should be cautious for older adults, people with kidney disease, and anyone taking interacting medications, but it cannot carry the efficacy claim by itself.

What to look at in the source

Relevant parts

• Magnesium functions and recommended intakes
• Deficiency, excess, and toxicity
• Interactions with medicines and kidney-related safety notes

Key findings

• NIH guidance covers intake, deficiency, and excess.
• Kidney function matters because magnesium is cleared by the kidneys.
• Medication interactions are an important practical issue.

How much weight to give it

For most readers, the main question is not how this source is classified internally. It is whether this source deserves real weight in the answer. This one is best treated as a high quality public health recommendation source.

This source is used to support the sections on deficiency, kidney disease, older adults, medication interactions, and the fact that magnesium is not risk-free. It does not prove that supplements improve sleep quality or reduce anxiety symptoms.

This source is trustworthy for what magnesium is, who may be deficient, and why kidney disease or interacting medicines matter. It should be treated as background safety guidance, not as evidence that magnesium is an effective sleep aid.

This NIH guidance is worth storing because it provides authoritative context on deficiency, intake, safety, and interactions. Even though it does not prove sleep or stress benefit, it helps define who should be cautious and why the topic is not just a wellness trend.

Limits to keep in mind

• Not a treatment trial
• Not designed to evaluate sleep or stress outcomes
• Consumer format is broad rather than deeply clinical